# RNN 2nd Gen Model Stryker Corporation Surgical & medical instruments

Stock predictor AI models:
Subscribe >> Deal exit on
Dec. 14, 2020
Deal entry on
Dec. 14, 2020
24.62%Expected margin
50.00% successful of 4 deals
$ 266.07 Last close price
at 29-oct-2021


Model's trade recommendations No return for period yet

0.49% Annual return

$62.42B Market Cap

β 0.70  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period
52wk return 37.92%
52wk Range
Sortino ratio 0.10
Sharpe ratio 0.06
Norm. RMSE 24.95%
Downside risk 4.69%
Volatility 0.00%
  • 1.88 (1.13%) Div (Yield)
  • BUY Analysts consensus recommendation

Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Stryker Corporation (SYK) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 19, 2017.

Market data for SYK model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for SYK.

Model is being retrained on a regular basis.

Float 346M
P/E 24.97
Shares Outstanding 374M
% Held by Insiders 7.40%
% Held by Institutions 75.62%
EPS (last reported FY) $6.49
EPS (last reported Q) $1.68
EPS, estimated (last reported Q) $1.60
Total revenues $12 B
Net income $1 B